Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Breast Cancer Predictive Genetic Testing Market Research Report 2012-2024

  • HEY2876591
  • 75 Pages
  • January 2019
  • Healthcare
Download Sample    Get Discount   
 

The global Breast Cancer Predictive Genetic Testing market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

High Penetrant Genes

Intermediate Penetrant Genes

Low Penetrant Genes

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Roche

Thermo Fisher Scientific

PerkinElmer

Quest Diagnostics

Myriad Genetics

Iverson Genetics

Cancer Genetics

OncoCyte Corporation

NeoGenomics

Invitae

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Hospitals

Clinics

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 High Penetrant Genes

1.2.1.2 Intermediate Penetrant Genes

1.2.1.3 Low Penetrant Genes

1.2.2 by Application

1.2.2.1 Hospitals

1.2.2.2 Clinics

1.2.2.3 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 High Penetrant Genes Market, 2013-2018

4.1.2 Intermediate Penetrant Genes Market, 2013-2018

4.1.3 Low Penetrant Genes Market, 2013-2018

4.2 Market Forecast

4.2.1 High Penetrant Genes Market Forecast, 2019-2023

4.2.2 Intermediate Penetrant Genes Market Forecast, 2019-2023

4.2.3 Low Penetrant Genes Market Forecast, 2019-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Hospitals Market, 2013-2018

5.1.2 Clinics Market, 2013-2018

5.1.3 Others Market, 2013-2018

5.2 Market Forecast

5.2.1 Hospitals Market Forecast, 2019-2023

5.2.2 Clinics Market Forecast, 2019-2023

5.2.3 Others Market Forecast, 2019-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2018

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2018

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2018

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2018

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2018

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2019-2024

6.2.2 North America Market Forecast, 2019-2024

6.2.3 Europe Market Forecast, 2019-2024

6.2.4 South America Market Forecast, 2019-2024

6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Roche

8.2 Thermo Fisher Scientific

8.3 PerkinElmer

8.4 Quest Diagnostics

8.5 Myriad Genetics

8.6 Iverson Genetics

8.7 Cancer Genetics

8.8 OncoCyte Corporation

8.9 NeoGenomics

8.10 Invitae

9 Conclusion

Table Product Specifications of Breast Cancer Predictive Genetic Testing

Table Products Segment of Breast Cancer Predictive Genetic Testing

Table High Penetrant Genes Overview

Table Intermediate Penetrant Genes Overview

Table Low Penetrant Genes Overview

Table Global Breast Cancer Predictive Genetic Testing Market by Type, 2011-2022 (USD Million)

Table Application Segment of Breast Cancer Predictive Genetic Testing

Table Hospitals Overview

Table Clinics Overview

Table Others Overview

Table Global Breast Cancer Predictive Genetic Testing Market by Application, 2011-2022 (USD Million)

Table Global Breast Cancer Predictive Genetic Testing Market by Region, 2011-2022 (USD Million)

Table Cost of Breast Cancer Predictive Genetic Testing

Table Market Dynamics

Table Policy of Breast Cancer Predictive Genetic Testing

Table GDP of Major Countries

Table High Penetrant Genes CAGR by Revenue and Volume, 2012-2018

Table Intermediate Penetrant Genes CAGR by Revenue and Volume, 2012-2018

Table Low Penetrant Genes CAGR by Revenue and Volume, 2012-2018

Table High Penetrant Genes CAGR by Revenue and Volume, 2012-2022

Table Intermediate Penetrant Genes CAGR by Revenue and Volume, 2012-2022

Table Low Penetrant Genes CAGR by Revenue and Volume, 2012-2022

Table Hospitals CAGR by Revenue and Volume, 2012-2018

Table Clinics CAGR by Revenue and Volume, 2012-2018

Table Others CAGR by Revenue and Volume, 2012-2018

Table Global Breast Cancer Predictive Genetic Testing Market by Vendors, 2012-2018 (USD Million)

Table Global Breast Cancer Predictive Genetic Testing Market by Vendors, 2012-2018 (in Volume)

Table Global Breast Cancer Predictive Genetic Testing Market Share by Vendors, 2012-2018 (USD Million)

Table Global Breast Cancer Predictive Genetic Testing Market Share by Vendors, 2012-2018 (in Volume)

Table Price Factors List

Table Roche Profile List

Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Thermo Fisher Scientific Profile List

Table Microecological Modulator Operating Data of Thermo Fisher Scientific (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table PerkinElmer Profile List

Table Microecological Modulator Operating Data of PerkinElmer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Quest Diagnostics Profile List

Table Microecological Modulator Operating Data of Quest Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Myriad Genetics Profile List

Table Microecological Modulator Operating Data of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Iverson Genetics Profile List

Table Microecological Modulator Operating Data of Iverson Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cancer Genetics Profile List

Table Microecological Modulator Operating Data of Cancer Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table OncoCyte Corporation Profile List

Table Microecological Modulator Operating Data of OncoCyte Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table NeoGenomics Profile List

Table Microecological Modulator Operating Data of NeoGenomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Invitae Profile List

Table Microecological Modulator Operating Data of Invitae (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370